SG11201506520TA - Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells - Google Patents

Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells

Info

Publication number
SG11201506520TA
SG11201506520TA SG11201506520TA SG11201506520TA SG11201506520TA SG 11201506520T A SG11201506520T A SG 11201506520TA SG 11201506520T A SG11201506520T A SG 11201506520TA SG 11201506520T A SG11201506520T A SG 11201506520TA SG 11201506520T A SG11201506520T A SG 11201506520TA
Authority
SG
Singapore
Prior art keywords
cholangiocytes
methods
stem cells
pluripotent stem
generating hepatocytes
Prior art date
Application number
SG11201506520TA
Other languages
English (en)
Inventor
Gordon Keller
Shinichiro Ogawa
Anand Ghanekar
Christine Bear
Binita M Kamath
Mina Ogawa
James Surapisitchat
Original Assignee
Univ Health Network
Hospital For Sick Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Health Network, Hospital For Sick Children filed Critical Univ Health Network
Publication of SG11201506520TA publication Critical patent/SG11201506520TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/237—Oncostatin M [OSM]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/724—Glycosyltransferases (EC 2.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/14—Coculture with; Conditioned medium produced by hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201506520TA 2013-02-18 2014-02-18 Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells SG11201506520TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361766002P 2013-02-18 2013-02-18
PCT/CA2014/000122 WO2014124527A1 (en) 2013-02-18 2014-02-18 Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells

Publications (1)

Publication Number Publication Date
SG11201506520TA true SG11201506520TA (en) 2015-09-29

Family

ID=51353452

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201506520TA SG11201506520TA (en) 2013-02-18 2014-02-18 Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells
SG10201803131TA SG10201803131TA (en) 2013-02-18 2014-02-18 Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201803131TA SG10201803131TA (en) 2013-02-18 2014-02-18 Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells

Country Status (12)

Country Link
US (2) US20160002595A1 (ja)
EP (1) EP2956540A4 (ja)
JP (3) JP2016517266A (ja)
KR (5) KR20220000930A (ja)
CN (2) CN113913366A (ja)
AU (1) AU2014218290B2 (ja)
CA (1) CA2901377C (ja)
HK (1) HK1218137A1 (ja)
IL (2) IL240616B (ja)
SG (2) SG11201506520TA (ja)
WO (1) WO2014124527A1 (ja)
ZA (1) ZA201506189B (ja)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3708564A1 (en) 2005-12-28 2020-09-16 Vertex Pharmaceuticals Incorporated A solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
EP3441458B9 (en) 2009-02-03 2023-08-23 Koninklijke Nederlandse Akademie van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells
CN113913366A (zh) * 2013-02-18 2022-01-11 大学健康网络 由多能干细胞生成肝细胞和胆管细胞的方法
WO2015020234A1 (ja) 2013-08-06 2015-02-12 武田薬品工業株式会社 ドパミン神経細胞の製造方法
CN104694456B (zh) * 2013-12-06 2018-05-29 中国科学院上海药物研究所 体外培养肝样细胞的方法及采用该方法培养的优化后肝样细胞
US10597633B2 (en) 2014-05-16 2020-03-24 Koninklijke Nederlandse Akademie Van Wetenschappen Culture method for organoids
EP3194569A4 (en) 2014-09-19 2018-03-07 Agency For Science, Technology And Research Differentiation of hepatocyte-like cells from stem cells
JP6746569B2 (ja) 2014-10-07 2020-08-26 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 嚢胞性線維症膜貫通コンダクタンス制御因子のモジュレーターの共結晶
GB201421092D0 (en) 2014-11-27 2015-01-14 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium
GB201421094D0 (en) 2014-11-27 2015-01-14 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium
JP5777127B1 (ja) * 2014-12-09 2015-09-09 公立大学法人横浜市立大学 原始腸内胚葉細胞及びその作製方法
HUE041518T2 (hu) * 2015-02-20 2019-05-28 Inst Nat Sante Rech Med Laminin alkalmazása pluripotens sejtek hepatocita sejtvonalhoz tartozó sejtekké történõ differenciálódásához
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
GB201510950D0 (en) 2015-06-22 2015-08-05 Cambridge Entpr Ltd In vitro Production of Cholangiocytes
CN108601801A (zh) 2015-10-05 2018-09-28 欧瑞3恩公司 基于鉴别和改善肝功能障碍来诊断和治疗帕金森病
JP6800987B2 (ja) * 2015-10-19 2020-12-16 フジフィルム セルラー ダイナミクス，インコーポレイテッド ウイルス受容性多能性幹細胞（ｐｓｃ）由来肝細胞の生産
CN106754636B (zh) * 2015-11-19 2019-08-30 中国人民解放军第二军医大学 体外诱导原代肝细胞胆管化并长期培养、扩增和分化的方法及其应用
GB201603569D0 (en) 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
GB201610748D0 (en) * 2016-06-20 2016-08-03 Koninklijke Nederlandse Akademie Van Wetenschappen Improved diffrentation method
US11116799B2 (en) * 2016-07-14 2021-09-14 Wisconsin Alumni Research Foundation Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures
JP7148134B2 (ja) * 2016-11-22 2022-10-05 国立大学法人京都大学 肝芽細胞から胆管上皮前駆細胞への段階的誘導方法
JP2020509736A (ja) * 2016-11-23 2020-04-02 バロリゼーション−エイチエスジェイ リミテッド パートナーシップＶａｌｏｒｉｓａｔｉｏｎ−Ｈｓｊ， Ｌｉｍｉｔｅｄ Ｐａｒｔｎｅｒｓｈｉｐ 被包化肝組織
US11530388B2 (en) 2017-02-14 2022-12-20 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of engineering human induced pluripotent stem cells to produce liver tissue
CN108660156A (zh) * 2017-03-16 2018-10-16 中国人民解放军军事科学院军事医学研究院 Cps1报告基因干细胞及其构建方法与应用
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN108865969B (zh) * 2017-05-11 2022-04-01 北京大学 Mapk/pkc信号通路激活剂促进人类胆管细胞分化和成熟
US10633907B2 (en) 2017-06-06 2020-04-28 Gto Access Systems, Llc Edge sensor for movable barrier
US20200308538A1 (en) * 2017-09-12 2020-10-01 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for treating liver disease and dysfunction
EP3702444A4 (en) * 2017-10-12 2021-06-02 Tokyo Institute of Technology METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN HEPATOCYTE
CN107904207A (zh) * 2017-11-13 2018-04-13 广东艾时代生物科技有限责任公司 一种利用三维培养系统诱导人诱导性多能干细胞获得成熟肝细胞的方法
CN108004201B (zh) * 2017-12-07 2021-06-04 香港大学深圳医院 一种成熟的多能干细胞来源肝脏细胞的获取方法
US20230026916A1 (en) * 2018-07-05 2023-01-26 Active Genomes Expressed Diagnostics, Inc Viral Oncogene Influences and Gene Expression Patterns as Indicators of Early Tumorigenesis
US11566229B2 (en) 2018-08-31 2023-01-31 Wisconsin Alumni Research Foundation Expansion and maintenance of adult primary human hepatocytes in culture
CN109337858B (zh) * 2018-09-20 2022-03-15 中国人民解放军第二军医大学 用于乙肝病毒感染的原代肝细胞来源的肝前体样细胞模型、制备方法及应用
CN117802031A (zh) * 2018-09-30 2024-04-02 中国科学院分子细胞科学卓越创新中心 肝细胞的体外扩增培养方法及应用
US20210395679A1 (en) * 2018-11-09 2021-12-23 Children's Hospital Medical Center In vitro cell culture system for producing hepatocyte-like cells and uses thereof
CN111304147A (zh) * 2018-12-11 2020-06-19 中国科学院分子细胞科学卓越创新中心 利用内胚层干细胞规模化制备功能性胆管细胞的方法及其应用
KR102146932B1 (ko) * 2018-12-18 2020-08-21 한양대학교 산학협력단 간 줄기세포의 담관 세포로의 분화 유도용 배지 조성물 및 이의 용도
CN111500525B (zh) * 2019-01-30 2023-05-02 中国科学院广州生物医药与健康研究院 一种组合物及其应用
CN113423818A (zh) * 2019-02-26 2021-09-21 北京大学 长期培养肝细胞的组合物和方法
CN111849859B (zh) * 2019-04-04 2023-04-07 中国科学院分子细胞科学卓越创新中心 一种经基因编辑的功能性肝实质细胞的制备方法及其应用
US20220220447A1 (en) * 2019-05-22 2022-07-14 The Cleveland Clinic Foundation Generating dorsal foregut, and anterior domain, endoderm cells
EP3980527A4 (en) * 2019-06-04 2023-09-27 University Health Network METHOD FOR PRODUCING AND USING LIVER CELLS
CN110373380B (zh) * 2019-06-14 2022-01-28 中国科学院生态环境研究中心 一种肝脏类器官模型及其建立方法和应用
KR102275911B1 (ko) 2019-08-27 2021-07-12 (주)유앤아이씨 모바일 앱 가상화 기술과 비콘을 이용한 가변형 매장 관리 시스템
CN111004770B (zh) * 2019-09-25 2022-08-23 中国人民解放军军事科学院军事医学研究院 功能性肝细胞诱导方法及其专用三维诱导培养基和应用
CN113151147B (zh) * 2020-01-23 2023-07-25 北京大学 功能性肝实质细胞及其制备方法
US20230383261A1 (en) * 2020-10-14 2023-11-30 Sana Biotechnology, Inc. Hepatocyte-like cells
CN115216436A (zh) * 2021-04-16 2022-10-21 中国科学院分子细胞科学卓越创新中心 利用多能干细胞建立具备双向分化潜能的肝干细胞系的方法及其应用
US20230016422A1 (en) 2021-06-23 2023-01-19 Crispr Therapeutics Ag Engineered cells with improved protection from natural killer cell killing
CN113667603B (zh) * 2021-08-13 2023-12-22 合肥燃音生物科技有限公司 一种肝脏类器官培养芯片及其制备方法与应用
CN114085805B (zh) * 2021-11-23 2024-05-24 中山大学附属第三医院（中山大学肝脏病医院） 冬眠动物干细胞分化为肝细胞的方法、利用该肝细胞筛选人体外细胞保护的代谢产物的方法
CN114149961B (zh) * 2022-02-09 2022-04-22 天九再生医学(天津)科技有限公司 一种多谱系肝脏类器官及其构建方法和应用
CN114181893B (zh) * 2022-02-09 2022-09-13 天津外泌体科技有限公司 肝脏双表型细胞的成熟方法
CN114874973B (zh) * 2022-04-24 2023-03-21 深圳市三启生物技术有限公司 获得成熟肝细胞的培养基及培养方法
CN115011550B (zh) * 2022-07-14 2024-04-26 广东乾晖生物科技有限公司 一种用于悬浮培养条件下诱导肝细胞分化成熟的诱导培养基以及方法
CN115851578B (zh) * 2022-12-23 2023-11-21 华南理工大学 一种3d悬浮诱导持续扩增肝祖细胞类器官和/或肝细胞类器官的试剂盒及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2690985A1 (en) * 2006-06-28 2008-01-03 Univeristy Of Kansas Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
WO2009013254A1 (en) * 2007-07-20 2009-01-29 Cellartis Ab A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells
ES2535614T3 (es) * 2008-07-08 2015-05-13 Oncomed Pharmaceuticals, Inc. Agentes de unión a Notch y antagonistas y métodos de uso de los mismos
WO2010049752A1 (en) * 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
US20100329986A1 (en) * 2009-01-06 2010-12-30 Greenbaum Linda E Adult Hepatic Progenitor Cells and Methods of Use Thereof
US9284531B2 (en) * 2009-06-18 2016-03-15 Takara Bio Europe Ab Differentiation of human pluripotent stem cells into cells expressing mature hepatocyte markers by 2D and bioreactor culture
WO2011009294A1 (zh) * 2009-07-23 2011-01-27 北京华源博创科技有限公司 通过诱导分化获得肝脏细胞、肝脏内胚层细胞和肝脏前体细胞的方法
CA2796251C (en) * 2010-04-13 2019-05-14 Cellular Dynamics International, Inc. Hepatocyte production by forward programming
AU2012272586B2 (en) * 2011-06-23 2016-07-07 The Children's Hospital Of Philadelphia Self-renewing endodermal progenitor lines generated from human pluripotent stem cells and methods of use thereof
CN113913366A (zh) 2013-02-18 2022-01-11 大学健康网络 由多能干细胞生成肝细胞和胆管细胞的方法

Also Published As

Publication number Publication date
JP2023052251A (ja) 2023-04-11
SG10201803131TA (en) 2018-06-28
IL240616B (en) 2021-07-29
KR20240024355A (ko) 2024-02-23
CN113913366A (zh) 2022-01-11
CN105121632B (zh) 2021-08-10
EP2956540A4 (en) 2016-08-03
IL240616A0 (en) 2015-10-29
WO2014124527A1 (en) 2014-08-21
KR20150119427A (ko) 2015-10-23
IL284523A (en) 2021-08-31
US20200157494A1 (en) 2020-05-21
CN105121632A (zh) 2015-12-02
EP2956540A1 (en) 2015-12-23
HK1218137A1 (zh) 2017-02-03
JP2016517266A (ja) 2016-06-16
JP7208870B2 (ja) 2023-01-19
CA2901377C (en) 2023-03-21
KR20230019992A (ko) 2023-02-09
KR20220000930A (ko) 2022-01-04
AU2014218290B2 (en) 2020-03-12
US20160002595A1 (en) 2016-01-07
KR102215508B1 (ko) 2021-02-16
CA2901377A1 (en) 2014-08-21
JP2019213538A (ja) 2019-12-19
AU2014218290A1 (en) 2015-09-03
KR20210018540A (ko) 2021-02-17
ZA201506189B (en) 2019-11-27

Similar Documents

Publication Publication Date Title
IL284523A (en) Methods for generating hepatocytes and cholangiocytes from multipotential gas cells
HK1246342A1 (zh) 產生源自幹細胞的β細胞的方法及其用途
IL250689B (en) Rearrangement of multipurpose stem cells
HK1218768A1 (zh) 使用熱穩定的 擴增和測序的方法
IL267283A (en) Methods and preparations for producing epicardial cells
SG11201509870QA (en) Culture vessel and culture method
HK1219050A1 (zh) 免疫保護性原代間充質幹細胞和方法
SG11201508027PA (en) Methods and compositions for mobilizing stem cells
HK1222200A1 (zh) 製備多能幹細胞的方法
EP2946523A4 (en) METHODS AND NODES FOR DETECTING ACTIVATION OF A DESERT CELL
GB201709599D0 (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
HK1220487A1 (zh) 全能幹細胞的誘導方法、及用該方法製備的全能幹細胞
EP2949746A4 (en) METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS
EP3070159A4 (en) METHOD AND PLANT FOR CURING PLURIPOTENT STEM CELLS
SG11201509767UA (en) Medium for culturing stem cells
EP2958985A4 (en) ELECTROPORATION METHODS AND DEVICES
GB201303101D0 (en) Media for stem cells
HK1224339A1 (zh) 用於生產幹細胞和分化細胞的改良系統及方法
EP2924110A4 (en) CELL CULTURE DEVICE AND CELL CULTURE METHOD
GB2517997B8 (en) Flow cell and method
SG11201508796SA (en) Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method
AP2014007636A0 (en) Biogas generation system and kit for biogas generation system
GB201307377D0 (en) Devices and methods for culture of cells
GB201415368D0 (en) Resetting pluripotent stem cells